Global Contraceptive Drugs Market is anticipated to grow at a CAGR of 4.32% by 2027 | DelveInsight Estimates
Contraceptive drugs are medication with the primary action to avoid conception by preventing the fusion of the gametes by employing different techniques such as the inhibition of follicular development, ovulation which is followed majorly in oral contraceptive pills, as well as the making the environment hostile for the sperms to survive as followed by spermicidal products.
DelveInsight’s Contraceptive Drugs Market Insights and Forecast report provides
the current and forecasted Contraceptive
Drugs Market forecasts for next five years, upcoming innovation in individual
market shares, challenges, drivers and barriers, market trends, and key
competitors in the Contraceptive Drugs
Market.
To know more about
the Contraceptive Drugs Market Report, click here: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Contraceptive Drugs Market are:
·
Global contraceptive drugs market was valued at
USD 8.59 billion in 2021, growing at a CAGR of 4.32% during the forecast period
from 2022 to 2027 to reach USD 11.04 billion by 2027.
·
As per the data provided by the World Health
Organization (2022), 4 million women living in low and middle-income countries
have unintended pregnancies annually across the globe.
·
The United Nation’s Department of Economic and
Social Affairs 2019 statistics mentioned that approximately 922 million women
of reproductive age (or their partners) use contraception methods comprising
various products of which contraceptive pills are one of the most common and
reliable sources for avoiding unintended pregnancies.
·
Some of the key market players operating in the
contraceptive drugs market includes Abbvie Inc, BAYER AG, Viatris Inc, Gedeon
Richter Plc., Agile Therapeutics, Evofem Biosciences, Inc., Amneal
Pharmaceuticals LLC., Pfizer Inc, Hana, Maxwellia Ltd., Piramal Enterprises,
Mankind Pharma, HLL Lifecare Limited, Theramex, Besins Healthcare, Marlborough
Pharmaceuticals, Teva Pharmaceuticals USA, Inc, and others
Request for free sample to know more about the Contraceptive Drugs Market facts: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key
market players operating in the contraceptive drugs market includes
·
Abbvie Inc
·
BAYER AG
·
Viatris Inc
·
Gedeon Richter Plc.
·
Agile Therapeutics
·
Evofem Biosciences, Inc.
·
Amneal Pharmaceuticals LLC.
·
Pfizer Inc
·
Hana
·
Maxwellia Ltd.
·
Piramal Enterprises
·
Mankind Pharma
·
HLL Lifecare Limited
·
Theramex
·
Besins Healthcare
·
Marlborough Pharmaceuticals
·
Teva Pharmaceuticals USA, Inc
·
And others
To know more about the Contraceptive Companies working in
the Drug Market, click here: https://www.delveinsight.com/sample-request/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Recent Developmental
Activities in Contraceptive Drugs Market:
• In May 2020, the US FDA approved Phexxi™ (lactic acid,
citric acid and potassium bitartrate) vaginal gel for the prevention of
pregnancy in females with reproductive potential.
• Bayer and DarĂ© Bioscience entered into an exclusive
license agreement for the US commercial rights to investigational hormone-free,
monthly contraceptive Ovaprene® in January 2020. As per this agreement, Bayer
may commercialize DarĂ©’s investigational contraceptive product, Ovaprene® in
the United States once approved by the FDA.
• Gedeon Richter Plc. signed an asset purchase agreement
with Janssen Pharmaceutica NV on December 2020, in respect of Janssen’s Outside
US Evra® transdermal contraceptive patch assets. The transaction amounted to
approximately around USD 263.5 million.
Know more about the recent developments in Contraceptive
Drugs Market by downloading the sample page, click here: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of Contraceptive Drugs Market Report:
·
Study Period: 2019-2027
·
Base Year: 2021
·
Forecast Period: 2022-2027
·
Contraceptive Drugs Market By Product Type (Oral
Contraceptive Pills [Combination And Progestin-Only], Injectables, Topical
Contraceptives [Gels & Jellies, Patches, And Creams])
·
Contraceptive Drugs Market By Distribution
Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, And Others)
·
Contraceptive Drugs Market By geography ((North
America, Europe, Asia-Pacific, and Rest of the World)
·
Contraceptive Drugs Companies: Abbvie Inc, BAYER
AG, Viatris Inc, Gedeon Richter Plc., Agile Therapeutics, Evofem Biosciences,
Inc., Amneal Pharmaceuticals LLC., Pfizer Inc, Hana, Maxwellia Ltd., Piramal
Enterprises, Mankind Pharma, HLL Lifecare Limited, Theramex, Besins Healthcare,
Marlborough Pharmaceuticals, Teva Pharmaceuticals USA, Inc, and others
DelveInsight’s
Analysis: Global contraceptive drugs market was valued at USD 8.59 billion
in 2021, growing at a CAGR of 4.32% during the forecast period from 2022 to
2027 to reach USD 11.04 billion by 2027.
Click here to know more about the Scope of the Contraceptive Drugs Market Report: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
1. Contraceptive Drugs Market Report Introduction
2. Contraceptive Drugs & Market Executive Summary
3. Regulatory Analysis
4. Contraceptive Drugs Market Key Factors Analysis
5. Contraceptive Drugs Market Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis on Contraceptive Drugs Market
7. Contraceptive Drugs Market Layout
8. Contraceptive Drugs Market Global Company Share Analysis;
Key 3-5 Companies
9. Contraceptive Drugs Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us
Request for Detailed TOC: https://www.delveinsight.com/sample-request/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Latest Report:
Pediatric
Obesity Market | France
Healthcare Outlook Report | Gastric
Neuroendocrine Tumours Market | Italy
Healthcare Outlook Report | Acanthamoeba
Keratitis Market | Progressive
Multifocal Leukoencephalopathy Market | Kernicterus
Market | Contraceptive
Drugs Market | Dental
Implants and Prosthesis Market | Precocious
Puberty Market | Menopause
Market | Urinary
Retention Market | Encephalitis
Market | Exophthalmos
Market | Premature
Ejaculation Market | Endoscopes
Market | Gout Market | Non-ST
Segment Elevation Acute Coronary Syndromes (NSTE ACSs) Market | Chronic
Progressive multiple sclerosis Market | Cough
Assisted Device Market | Gastroenteropancreatic
Neuroendocrine Tumors (GEP-NETs) Market | Gastroparesis
Market | Gouty
Arthritis (Gout) Market | Graves
Orbitopathy Market | Graves’
Disease Market | Head
and Neck cancer (HNC) Market
About DelveInsight
DelveInsight is a leading Business Consultant and Market
Research firm focused exclusively on life sciences. It supports Pharma
companies by providing comprehensive end-to-end solutions to improve their
performance. Get hassle-free access to all the healthcare and pharma
market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
Comments
Post a Comment